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ABSTRACT 
 
Since 1998, there have been six reported human cases of myositis in Australia, 
attributable to infection with the nematode Haycocknema perplexum. However, an 
unequivocal diagnosis of H. perplexum infection and associated disease has been 
seriously compromised by a lack of molecular markers for this nematode. Here, we 
report new cases of disseminated myositis in two male patients from the states of 
Queensland and Tasmania in Australia, respectively; genetically characterize the 
causative agent from each case; and, also establish a PCR-based sequencing approach 
as a tool to support the diagnosis of future cases and to underpin epidemiological 
studies. 
 
Keywords: Disseminated myositis, human, Australia, nematode, Haycocknema perplexum  
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1. Introduction  
 
Myositis is an inflammation of muscle(s), characterized by pain, swelling, and/or 
weakness. There are many aetiologies of myositis, including injury, medicines, toxins, 
excessive exercise/exertion, chronic diseases (involving the immune or endocrine 
system), electrolyte imbalance and infections. Infectious myositis can involve one or 
more species of viruses, bacteria, fungi and/or parasites (Crum-Cianflone, 2008, 
2010). For parasitic myositis, clinical diagnosis is often assisted by the use of 
complementary laboratory tests that detect and attempt to microscopically identify the 
agent in histological sections of muscle biopsies from patients. However, diagnosis is 
often not reliable without the genetic identification of the agent using molecular 
methods. 
Parasitic myositis is mainly reported to be associated with protists, flatworms or 
roundworms (nematodes), the latter of which often involves Toxocara and Trichinella 
species (Crum-Cianflone, 2008). However, some unusual myositis cases involving 
nematodes have been reported in the literature. For instance, since 1998, there have 
been six human cases of disseminated myositis (inflammation of multiple muscle 
groups) in the States of Queensland and Tasmania of Australia (McKelvie et al., 
2013), attributed to the nematode Haycocknema perplexum (Spratt et al., 1999). In 
these cases, clinical diagnosis was made on the basis of progressive muscle weakness, 
weight loss and/or dysphagia, complemented by the microscopic 
detection/identification of the nematode in muscle biopsies (Dennett et al., 1998; 
Spratt et al., 1999; Basuroy et al., 2008; McKelvie et al., 2013), elevated eosinophil 
and creatine kinase levels in blood and an exacerbation of clinical signs following 
anti-inflammatory (usually corticoid steroid) treatment against the myositis. 
Parasitological diagnosis from muscle biopsies has relied on the microscopic 
identification of the non-encysted, intra-fibrillar nematode, which is ~ 350 µm in 
length and 20 µm in width, and has a rounded cephalic end and a sharply tapered tail; 
female worms within the muscle are often gravid (Basuroy et al., 2008). However, the 
diagnosis of H. perplexum infection, and associated disease, is consistently 
challenging and has been seriously compromised by a lack of molecular markers for 
this nematode. In the present study, we report two new cases of disseminated myositis 
in patients from Queensland and Tasmania, from where all previous H. perplexum 
cases had been reported (cf. McKelvie et al., 2013). Both of these cases were 
consistent with previous cases, in terms of symptomatology and the presence of 
characteristic non-encysted nematodes in muscle biopsy material. Importantly, here, 
for the first time, we genetically characterized these agents, and established PCR-
based DNA sequencing as a laboratory-based tool for future suspected cases and 
epidemiological studies. 
 
 
2. Materials and methods 
 
2.1. Human case histories 
 
2.1.1. Case in Queensland 
 
In December 2014, a 30 year-old indigenous male Australian presented with a 
progressive proximal muscle weakness, weight loss and muscle wasting. In 2012, he 
first noticed muscle weakness in both arms and legs, and had difficulty in getting up 
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from the sitting position. There was no other symptomatology. In particular, he had 
no loss of appetite, fever, rash or pain in joints, change in sensation, muscle cramps, 
or bladder or bowel dysfunction. From 2012 to 2014, the muscle weakness gradually 
progressed distally.  
This patient had had no medical history of diabetes, hypertension, hyperlipidaemia 
or ischaemic heart disease, but had been treated against depression with 
desvenlafaxine. This patient had lost his job because of muscle weakness, and became 
bed-bound, requiring assistance for daily tasks and walking. He had only travelled in 
the Mackay region, Toowoomba and Townsville. He had no exposure to wild 
animals, and had never consumed raw or undercooked “bush-meat” from native 
wildlife.  
In September 2013, clinical biochemistry analyses revealed elevated levels of 
serum alanine transaminase (ALT; 142 U/l; normal: <45 U/l) and aspartate 
trasaminase (AST; 81 U/l; normal: <35 U/l). ALT and AST remained elevated over 
time, with peaks of 291 U/l and 118 U/l, respectively, in April 2015. Blood 
examination showed an elevated eosinophil count of 1.24 x 10
9 
cells/l (normal range: 
0.1-0.6 x 10
9
/l). Serological testing detected anti-Strongyloides antibody, but stool 
examination for nematode larvae was test-negative. Nonetheless, the patient had been 
treated with ivermectin against Strongyloides infection. Microscopic examination of a 
liver biopsy did not reveal any pathological findings. 
In December 2014, neurological examination revealed a proximal weakness in 
both the upper and lower limbs, with a Grade 3-4 muscle weakness, but no detectable 
weakness distally. There was no detectable impairment of sensation or reflexes. 
Although he had a significant wasting of the muscles, there was no detectable joint or 
cardio-respiratory involvement. Nerve conduction was normal, and electromyography 
revealed low amplitude, polyphasic potentials, consistent with myopathy. Serum 
creatine kinase levels were elevated at 2840 to 3400 U/l (normal range: 46-171 U/l). 
No auto-antibodies associated with liver or collagen vascular disease were detected.  
In February 2015, histopathological examination of a biopsy from the quadriceps 
femoralis muscle showed a severe, active chronic inflammatory myopathy with 
prominent plasma cell infiltration. Based on this presumptive diagnosis, the patient 
was given immunoglobulins intravenously and put on an oral course of prednisolone 
and ivermectin for the presumed Strongyloides infection. Following this treatment 
regimen, muscle weakness decreased significant over the next 1-2 months. However, 
the patient developed bulbar symptoms, with dysphagia for solids, dysphonia and 
nasal regurgitation of food being prominent signs. His extra-ocular and neck muscles 
were demonstrably weak. He had also lost ~ 20 kg over the previous two years, and 
had occasional episodes of night sweats. The computer tomographic (CT) scans of the 
chest, abdomen and pelvis revealed no abnormal findings. Serological testing for anti-
Strongyloides antibody remained positive, but stool examination for nematode larvae 
was test-negative. 
In May 2015, due to continued muscle weakness, the examination of another muscle 
biopsy revealed parasitic myositis, with scattered myocytes containing single elongate 
nematodes (an average of 50 per transverse section). Many of the intracellular 
nematodes had dark brown, haemazoin-like pigmentation. In addition, there was 
evidence of muscle fibrosis necrosis and regeneration as well as patchy interstitial 
inflammation involving mainly mononuclear cells and eosinophils. The 
morphological features of this nematode were consistent with those of H. perplexum 
(Fig. 1). Following the detection of the nematodes in musculature, immunoglobulin 
and immunosuppressive therapy ceased immediately, and the patient was 
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administered albendazole (400 mg twice a day) for a period of four months. After this 
treatment, the patient’s muscle weakness, dysphagia and dysphonia had ceased. 
Importantly, he gained significant weight, mobilized independently and was able to 
resume his job. He remains under surveillance as an outpatient for any further clinical 
symptoms.  
 
2.1.2. Case in Tasmania  
 
In 2014, a 72 year-old male resident from Kingston, Tasmania, who was retired for 
some years from working in Western Australia, Queensland and Tasmania, presented 
with a myositis linked to gradual muscle weakness over a period of several years, was 
a recreational hunter and liked to consume bush-meat (e.g., wallaby) jerky. 
Serological evaluations revealed no evidence of viral (HIV, HCV and HBV) 
infections, but did suggest the presence of (possibly cross-reactive) antibodies against 
Strongyloides. Coproscopic examinations showed no evidence of parasitic (worm or 
protistan) infections. From April to December 2014, a series of clinical and laboratory 
assessments were undertaken. During this time, the patient exhibited a persistent 
blood eosinophilia (2.0-2.4 x 10
9
 cells/l) and elevated creatine kinase (2068-2082 U/l) 
levels in blood. In June 2014, a histopathological examination of a muscle biopsy 
from the right lateral vastus muscle revealed a chronic, moderately severe myopathy, 
with active fibre necrosis and florid inflammatory infiltrate, including lymphocytes, 
plasma cells and eosinophils within the fascicle. As these findings were initially 
interpreted as a rheumatoid process, the patient was treated with methyl-prednisolone 
and methotrexate at therapeutic doses. Subsequently, on 11 November 2014, he was 
admitted to hospital after a deterioration of his condition, and was administered 
therapeutic doses of methyl-prednisolone intravenously for three days as well as 
cyclophosphamide. Thereafter, his muscle weakness decreased, and he was 
discharged by mid November 2014. While his blood eosinophil count was low (0.01-
0.2 x 10
9
 cells/l), creatine kinase remained high (1607-1968 U/l). Finally, at the end 
of December 2014, a histopathological examination of a muscle biopsy from the left 
lateral vastus muscle detected nematodes that appeared to be consistent in 
morphology with H. perplexum (cf. Fig. 1). The patient was treated with therapeutic 
doses of albendazole (400 mg twice daily) and prednisolone for some weeks; he 
improved clinically and was then discharged in March 2015. He remains on 
surveillance as an outpatient for any further clinical developments.  
 
2.2. Microscopic methods 
 
A portion of the muscle biopsy from the Queensland case (see subsection 2.1.1.) was 
snap-frozen in liquid nitrogen and transverse sections (5 µm thickness) were prepared 
using Leica CM1850 cryostat (Leica Microsystems Pty Ltd, Australia). The sections 
were stained with Harris’ haematoxylin & eosin (Sheenan and Hrapchak, 1980) and 
examined by routine light microscopy. A second portion of the biopsy was fixed 
overnight in 3% glutaraldehyde in 0.1 M phosphate buffer (pH 7.2). Longitudinal 
sections were prepared using the Leica EMTP automated tissue processor (Leica 
Microsystems Pty Ltd, Australia). Specifically, the tissue was post-fixed in 1% 
modified osmium tetroxide (containing 1.5% potassium ferrocyanide) (Proscitech, 
Australia), stained en bloc with 2% uranyl acetate (Proscitech, Australia), and then 
infiltrated and embedded in Procure 812 resin (Proscitech, Australia). Ultra-thin 
sections of 70-100 nm thickness were cut with the Leica UC7 Ultratome (Leica 
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Microsystems Pty Ltd, Australia), mounted on grids, and post-stained with 2% lead 
citrate (Leica Microsystems Pty Ltd, Australia). Ultrastructural examination was 
undertaken using a JEOL 1011 electron microscope (JEOL Australasia Pty Ltd, 
Australia) at 100 kV. Images were acquired with the Gatan Orius SC1000, model 832 
CCD camera (Thompson Scientific Instruments Pty Ltd, Australia). 
 
2.3. Molecular methods 
 
Genomic DNA was extracted separately from individual frozen (Queensland case) 
and ethanol-fixed (Tasmanian case) muscle biopsies using the Powersoil
©
 kit (MoBio, 
USA). Muscle biopsies were taken from both patients by registered medical surgeons, 
and were donated (with consent from the patients) to the investigators at the 
University of Melbourne for molecular analyses. 
Two gene regions were amplified by PCR and the amplicons directly sequenced. 
First, the small subunit of nuclear ribosomal RNA gene (SSU) was amplified in two 
overlapping fragments using primer pair 1096F (forward: 5’-
GGTAATTCTGGAGCTAATAC-3’) and 1912R (reverse: 5’-
TTTACGGTCAGAACTAGGG-3’) (~815 bp), and primer pair 1813F (forward: 5’-
CTGCGTGAGAGGTGAAAT-3’) and 2646R (reverse: 5’-
GCTACCTTGTTACGACTTTT-3’) (~830 bp) (Holterman et al., 2006). For both 
amplifications, the cycling protocol was 94 °C/5 min (initial denaturation), followed 
by 5 cycles of 94 °C/30 sec (denaturation), 45 °C/30 sec (annealing) and 72 °C/70 sec 
(extension), followed by 35 cycles of 94 °C/30 sec, 54 °C/30 sec, and 72 °C/70 sec, 
with a final extension at 72 °C/5 min. Second, the cox-1 gene was amplified using the 
primer pair RhigoCoxF (forward: 5’-TTTTTTGGACATCCTGAGGTGTAT-3’) and 
RhigoCoxR (reverse: 5’-CAGACTCAACACATAATGAAAATG-3’) (~450 bp), 
designed for this study by aligning conserved regions of the cox-1 gene of Rhigonema 
thysanophora (rhigonematid),  Gongylonema pulchrum (spirurid) and Philometroides 
sanguineus (camallanid), represented by accession nos. KF534714, KM264298 and 
KM111526, respectively. The cycling protocol was 94 °C/5 min (initial denaturation), 
followed by 35 cycles of 94 °C/30 sec (denaturation), 47 °C/30 sec (annealing) and 72 
°C/30 sec (extension), with a final extension at 72 °C/5 min. 
The size and intensity of the amplicons were assessed by electrophoresis (7 V/cm) 
in 1.5% agarose gels using TBE (65 mM Tris-HCl, 27 mM boric acid, 1 mM EDTA, 
pH 9; Bio-Rad, USA) as the buffer. Following electrophoresis, gels were stained with 
ethidium bromide and their size estimated by comparison to X174-HaeIII 
(Promega, USA) markers. Aliquots (5 µl) of individual amplicons (undigested) were 
treated with ExoSAP-IT (Affymetrix, USA), according to the manufacturer’s 
instructions, and then subjected to direct, automated sequencing (BigDye Terminator 
v.3.1 chemistry, Applied Biosystems, USA) in both directions using the same primers 
as employed for PCR amplification. 
 
2.4. Phylogenetic analyses  
 
SSU sequences (consensus alignment length: 2258 bp) were aligned using R-
Coffee (Moretti et al 2008) (which takes into account predicted secondary structures 
for noncoding sequences) and Mesquite v 3.03 (Maddison and Maddison 2015). The 
cox-1 sequences were aligned (consensus alignment length: a 248 bp) using the 
program ClustalW (Larkin et al., 2007) in Mesquite. For SSU, a preliminary tree was 
constructed using publicly available sequences representing the major clades of the 
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Nematoda (cf. Blaxter et al., 1998) (Supplementary Fig. 1). This placed H. perplexum 
within the secernentean nematodes. In order to gain a finer phylogenetic resolution 
while maintaining a reasonable alignment, representative sequences from 
neighbouring clades from the extensive study by van Megen et al., (2009) were 
included in the final alignment of SSU sequences. Outgroups used in the SSU analyses 
were Axonolaimus sp. and Cylindrolaimus communis (representing Clade 5A; van 
Megen et al., 2009). For cox-1, a 248 bp alignment (limited to the size of the available 
Riouxgolvania kapapkamui sequence) was used to construct a tree including 
representative nematodes from GenBank, and Trichinella spiralis and Trichuris 
trichiura as outgroups. The number and range of cox-1 sequences available on 
GenBank for nematodes is far less compared to those available for SSU therefore SSU 
was selected to provide finer phylogenetic resolution.  
Bayesian inference (BI) (SSU and cox-1) and maximum likelihood (ML) (for SSU 
only) analyses of sequence data were conducted using MrBayes v3.2.3 (Ronquist and 
Huelsenbeck, 2003) and Randomized Axelerated Maximum Likelihood for High 
Performance Computing (RAxML HPC v. 8.2; Stamatakis, 2006). The likelihood 
parameters set for the BI analysis of sequence data were based on the Akaike 
Information Criteria test in jModeltest v.2.1.7 (Posada 2008). For the analyses of SSU 
and cox-1 sequence data sets, the number of substitutions was set at six, with a 
gamma-distribution and a proportion of invariable sites. The aligned COX-1 amino 
acid sequence data were run, with the rate matrix set to ‘mixed’. For each tree, 
posterior probability (pp) values were calculated by running 2,000,000 generations 
with four simultaneous tree-building chains. Trees were saved every 100th 
generation. At the end of each run, the standard deviation (SD) of split frequencies 
value was ~0.01, and the potential scale reduction factor approached one. For each 
analysis, a 50%-majority rule consensus tree was constructed based on the final 75% 
of trees produced by BI. Analyses were run three times to ensure convergence and 
insensitivity to priors. For RAxML the general time reversible (GTR) with gamma 
parameter was applied using 200 bootstraps; the topologies of trees constructed using 
BI and ML were almost identical.  
 
3. Results 
 
From the genomic DNAs from two muscle biopsy samples representing the human 
cases from Queensland and Tasmania, we sequenced 1,603 bp and 852 bp of the SSU 
gene, respectively, and found a single base difference between the sequences over the 
corresponding 852 bp, interpreted to represent intraspecific variability. A comparison 
with publicly available sequences for nematodes showed at least 10% difference from 
the best-matching sequences representing Carnoya filipjevi (Rhigonematomorpha), 
Cyrnea seurati (Spiruromorpha) and Pseudonymus islamabadi (Oxyuridomorpha). 
The consensus phylogenetic tree constructed using SSU data places H. perplexum 
between members of Clades 8A (Oxyuridomorpha) and 8B (Ascaridomorpha) (cf. van 
Megen et al. 2009) (see Fig. 2) and within the Secerentea rather than the 
Chromadorea (cf. Spratt et al., 1999; Spratt 2014).  
We also sequenced 440 bp of the cox-1 gene from the same two genomic DNAs, 
and calculated 5.7% nucleotide difference between the two sequences, relating to 24 
synonymous and one non-synonymous mutations. The one amino acid change over 
146 positions of the COX-1 sequence linked to the 5.7% nucleotide difference in cox-
1 between the two samples is suggested to represent intraspecific variability, a 
statement supported by the single nucleotide difference in the partial SSU sequence 
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(852 bp). The consensus phylogenetic tree constructed using available cox-1 data 
(consensus alignment length: 240 bp) (Fig. 3) shows a clustering of the two sequences 
representing H. perplexum from the two localities to the exclusion of sequences 
representing a range of other nematode taxa (n = 69) (Fig. 3). In this tree, H. 
perplexum groups most closely with oxyurid nematodes (although cox-1 should not be 
used to infer relationships among distantly related nematodes). Interestingly, the level 
of sequence difference in cox-1 between H. perplexum and the muspiceoid R. 
kapapkamui was 25.3% (Fig. 3), showing considerable genetic distinctiveness. 
Additional trees constructed using a subset of sequences (consensus alignment length: 
440 nucleotides or inferred amino acid sequence data) had similar topologies and 
support values at the nodes (not shown). 
 
4. Discussion 
 
The two cases of parasitic myositis described here were consistent clinically with 
those reported previously to be linked to H. perplexum infection (Dennett et al., 1998; 
Basuroy et al., 2008; McKelvie et al., 2013) and also clustered with them 
geographically, suggesting a particular association among the parasite, geographic 
loci and humans. PCR-based sequencing was able to define, for the first time, genetic 
markers for the causative agent, and phylogenetic analyses allowed us to infer that 
this nematode belongs to the Secernentea, and is positioned between the 
Oxyuridomorpha and Ascaridomorpha. Although the nematodes from the two 
disparate locations (Tasmania and Queensland) were shown to be genetically distinct, 
present evidence suggests that this distinctiveness likely represents within-species 
genetic variation in the nematode rather than difference between species. Nonetheless, 
these two genotypes or haplotypes of nematode might differ in their biology (e.g., life 
cycle and host animal/s) and/or their epidemiology (host range/s and transmission). 
Irrespective of this variability, we have been able to define genetic markers for this 
nematode, which we consider very likely to represent H. perplexum based on its 
morphological features, as observed in transverse sections of muscle biopsies, the 
location of the human cases and also the expression of disease. 
In contrast to the molecular findings here, H. perplexum had been assigned to the 
family Robertdollfusidae Chabaud and Campana, 1950, of the order Muspiceida Bain 
and Chabaud, 1959, and class Chromadorea (Spratt et al., 1999; Spratt 2014). Other 
muspiceoids are found in subcutaneous connective tissue of mice, skin cysts of bats, 
eyes and brains of corvids, circulatory system of marsupials and ear capillaries of 
reindeer (Spratt, 2014). Riouxgolvania kapapkamui (found in bats) is the only 
muspiceoid  previously characterized molecularly; the molecular evidence suggested 
that this taxon muspiceoid belongs to the Secernentea based on the mitochondrial 
cytochrome oxidase subunit 1 gene (cox-1) sequence (Hasegawa et al., 2012), 
consistent with the nematodes characterized genetically in the present study. The 
considerable genetic difference (25.3%) in cox-1 between H. perplexum and R. 
kapapkamui also suggests that the Muspiceoidea are not a monophyletic group. 
However, further molecular evidence is needed for other muspiceoid nematodes to 
elucidate their phylogenetic relationships, because the present results using nuclear 
and mitochondrial gene data contrast the findings obtained using morphological data 
sets (Bain and Chabaud, 1968, 1979; Spratt and Nicholas, 2002).   
As H. perplexum is distantly related (at least 10% sequence difference in SSU) to 
the other nematodes for which sequence data are presently available, it is not possible 
to make major inferences about its life cycle based on the neighbouring taxa. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 9 
However, some generalizations can be made. H. perplexum falls amongst members of 
the Oxyurida, Ascaridida and the Rhigonematida, all of which have monoxenous 
(direct) life cycles. The Oxyurida have an ancestral history with arthropods, as do the 
Rhigonematida, which are found in millipedes (Sudhaus, 2010). The oxyurids most 
closely related to H. perplexum are Thelastoma krausi and Leidynema portentosae, 
both found in millipede and cockroach, respectively (van Waerebeke, 1978; Carreno, 
2007). The ascarids are thought to have switched hosts, from insects to tetrapods 
(Sudhaus, 2010). Larval forms of other muspiceoid nematodes have been found in 
insects. For instance, Durikainema sp. (found in tree kangaroos) was recovered from 
the abdomen of the biting midge Culicoides victoriae. In addition, an undescribed 
Robertdollfusidae was found in the gut of the blackfly, Simulium damnosum, in 
Cameroon (Spratt et al., 1999). With these related nematodes in mind, it could be 
proposed that H. perplexum uses an arthropod as an intermediate host and has 
accidentally found its way into humans. Another possibility is that H. perplexum is 
transmitted via the consumption of undercooked bush-meat from a native marsupial, 
as hypothesized for the first human case of disease caused by H. perplexum, initially 
misdiagnosed as Trichinella pseudospiralis (see Andrews et al., 1994; Spratt, 2005). 
However, thus far, only two of eight cases were proposed to relate to the consumption 
of bush-meat on one occasion (cf. Basuroy et al., 2008; McKelvie et al., 2013). 
In conclusion, as seen from the clinical cases presented here, the diagnosis of 
parasitic myositis is a major clinical challenge. Although considered as rare, disease 
caused by H. perplexum in humans in Australia might be an occult or emerging issue, 
possibly affecting some people by subclinical infection/s in what presently appear to 
be two endemic foci (Queensland and Tasmania). The definition of nuclear and 
mitochondrial genetic markers for nematodes that we presently consider to represent 
H. perplexum (Spratt et al., 1999) now provides a sound basis for routine molecular 
diagnosis of parasitic myositis in human patients suffering from debilitating and 
progressive muscle wastage and associated complications, in combination with 
conventional clinical, biochemical and immunological tests. Moreover, the PCR-
based sequencing approach established here would be a useful research tool to 
undertake surveys of potential reservoir animals or vectors for the occurrence of the 
present and related nematode genotypes in Australia or elsewhere, and to support 
studies of the biology and transmission of these/this enigmatic worm/s. 
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FIGURES 
 
 
 
Fig. 1. Light (panels A-B) and electron microscopic (panels C-D) images from 
sections through skeletal muscle biopsies from an adult male patient (affected by 
myositis) from Queensland, Australia, showing evidence of an intrafibrillar nematode 
morphologically consistent with Haycocknema perplexum. Panel A: Transverse 
section (haematoxylin & eosin) through five developing larvae within a female 
nematode within a muscle cell. Panel B: Transverse sections of three nematodes in 
different muscle cells. Panel C: End of nematode, showing fine transverse cuticular 
striation (S). Panel D: Section through vulva (V) of female nematode, and faint 
transverse cuticular striation (S). 
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Fig. 2. Phylogenetic tree constructed from nuclear small subunit ribosomal RNA gene 
(SSU) sequence data (~1600 nucleotides) for selected nematodes representing Clades 
5 to 8 (cf. van Megen et al., 2009) using the Bayesian inference method. The longest 
SSU sequence from the causative agent from an adult male patient (affected by 
polymyositis) from Queensland, Australia (see text), and inferred to represent 
Haycocknema perplexum (bold), is positioned between the Oxyuridomorpha and 
Ascaridomorpha. Nodal support values are given as posterior probabilities (Bayesian), 
followed by bootstrap support (maximum likelihood). Infraorders and superfamilies 
are labelled with vertical bars. GenBank accession numbers precede the nematode 
taxa. A scale bar indicates the number of substitutions per site. 
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Fig. 3. Phylogenetic tree constructed from mitochondrial cytochrome c oxidase 
subunit 1 gene (cox-1) sequence data (~240 nucleotides) from selected nematodes 
representing major nematode clades. The two sequences from the causative agents 
originating from male human patients from Queensland and Tasmania, respectively, 
and inferred to represent Haycocknema perplexum (bold) are genetically distinctive 
from the morphologically similar muspiceoid nematode Riouxgolvania kapapkamui. 
Nodal support is given as a posterior probability. GenBank accession numbers 
precede the nematode taxa. The scale bar indicates the number of substitutions per 
site.  
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Highlights 
 Two new human cases of parasitic polymyositis consistent with H. perplexum infection 
 
 First molecular characterization of the nematodes 
 
 Established PCR-based DNA sequencing as a laboratory-based tool for diagnosis 
